Table 3.

Comparison of percentages of B-cell subsets in lymphocytes between patients with ITP and HCs

B-cell subsetBM (%)PB (%)
Patients with ITPHCsPPatients with ITPHCsP
Immature B 0.22 ± 0.07 0.53 ± 0.12 .029    
Naive B 4.66 ± 0.66 12.52 ± 1.75 <.001 4.95 ± 0.61 3.16 ± 0.38 .027 
Memory B 1.52 ± 0.25 1.51 ± 0.24 .992 1.28 ± 0.22 1.14 ± 0.27 .693 
Plasmablast 0.06 ± 0.03 0.07 ± 0.03 .782 0.06 ± 0.01 0.05 ± 0.02 .617 
SLPC 0.79 ± 0.26 1.03 ± 0.26 .543 0.018 ± 0.005 0.016 ± 0.008 .843 
Breg 0.58 ± 0.15 2.84 ± 0.34 <.001 0.05 ± 0.01 0.18 ± 0.04 .004 
B-cell subsetBM (%)PB (%)
Patients with ITPHCsPPatients with ITPHCsP
Immature B 0.22 ± 0.07 0.53 ± 0.12 .029    
Naive B 4.66 ± 0.66 12.52 ± 1.75 <.001 4.95 ± 0.61 3.16 ± 0.38 .027 
Memory B 1.52 ± 0.25 1.51 ± 0.24 .992 1.28 ± 0.22 1.14 ± 0.27 .693 
Plasmablast 0.06 ± 0.03 0.07 ± 0.03 .782 0.06 ± 0.01 0.05 ± 0.02 .617 
SLPC 0.79 ± 0.26 1.03 ± 0.26 .543 0.018 ± 0.005 0.016 ± 0.008 .843 
Breg 0.58 ± 0.15 2.84 ± 0.34 <.001 0.05 ± 0.01 0.18 ± 0.04 .004 

BM, bone marrow; HCs, healthy controls; ITP, immune thrombocytopenia; PB, peripheral blood; SLPC, short-lived plasma cell.

or Create an Account

Close Modal
Close Modal